Response to the Call on the Pharmaceutical Industry to Voluntarily Suspend Marketing and Advertising of Opioids

In June 2018, the Minister of Health sent a letter to manufacturers and distributors of opioids in Canada requesting that they respond to the opioid crisis by immediately suspending any and all marketing and advertising of opioids to health care professionals on a voluntary basis.

To encourage a response from companies who had not yet responded to the Minister’s request, on January 31, 2019, Health Canada sent follow up letters to fifteen companies with opioid products on the market in Canada.

The following table lists responses received as of March 26, 2019.

The correspondence can be ordered through the Meetings and Correspondence on Marketing and Advertising of Opioids.

To order all responses:

Firm Status of Response
AA Pharma Inc. Responded
AbbVie Corporation Responded
Accord Healthcare Inc.  
Actavis Group PTC ehf. Responded
Actavis Pharma Company Responded
Adapt Pharma Canada Limited  
Allergan Inc. Responded
Apotex Inc. Responded
Aralez Pharmaceuticals Canada Inc. Responded
Aspen Pharmacare Canada Inc. Responded
Astrazeneca Canada Inc. Responded
Auro Pharma Inc. No Response
Bard Pharmaceuticals (1990) Inc.  
Baxter Corporation  
Biogen Canada Inc.  
Biomed Pharma Responded
Biosyent Pharma Inc.  
Boehringer Ingelheim (Canada) Limited  
Bristol-Myers Squibb Canada Responded
Buzzz Pharmaceuticals Ltd. (Dublin)  
Canada's Medical Device Technology Companies (Medec)  
Canadian Generic Pharmaceutical Association Responded
Church & Dwight Canada Corporation Responded
Cipher Pharmaceuticals Inc. No Response
Collegium Pharmaceutical, Inc.  
Confab Laboratories Inc. Responded
Dentsply Canada Limited  
Dominion Pharmacal, a sister company of Pharmascience Inc. Responded
Dra Pharmedev Canada Inc.  
Eli Lilly Canada Inc.  
Emd Serono, A Division Of EMD Inc., Canada  
Endo Ventures Inc. Responded
ERFA Canada 2012 Inc.  
Eisai Limited  
Ethypharm Responded
Euro-Pharm International Canada Inc.  
Fresenius-Kabi Canada Limited  
Generic Medical Partners Inc.  
GlaxoSmithKline Inc.  
Groupement Provincial de l'industrie du médicament (GPIM)  
GW Pharmaceuticals  
Hansamed Limited  
HLS Therapeutics Inc.  
Hoffmann-La Roche Limited  
Hospira Healthcare Corporation, a Pfizer Company Responded
ICU Medical Canada Responded
INDIVIOR Canada Ltd Responded
Innovative Medicines Canada Responded
Intrinsik Corp.  
Ionis Pharmaceuticals, Inc.  
JAMP Pharma Corporation Responded
Janssen Inc. Responded
Knight Therapeutics Inc.  
Laboratoire Atlas Responded
Laboratoire Riva Inc. Responded
Laboratoires Trianon Inc.  
Lundbeck Canada Inc.  
Lupin Pharma Canada  
Mallinckrodt Canada ULC No Response
Mantra Pharma Inc.  
Mapi Group  
Marcan Pharmaceuticals Inc. Responded
Merck Canada Inc.  
Mint Pharmaceuticals Inc. Responded
Mitsubishi Tanabe Pharmaceutical Development America, Inc.  
Mylan Pharmaceuticals ULC (BGP Pharma ULC) Responded
Novartis Pharmaceuticals Canada Inc.  
Odan Laboratories Ltd.  
Omega Laboratories Limited Responded
Otsuka Canada Pharmaceutical Inc.  
Paladin Labs Inc. Responded
Patriot a Division of Janssen Inc.  
Pendopharm a division of Pharmascience Inc. Responded
Peptigroupe Inc.  
Pfizer Canada Inc. Responded
Pfizer Consumer Healthcare, a division of Pfizer Canada Inc. Responded
Pharmapar Inc. Responded
Pharmascience Inc. Responded
Pharmazeutische Fabrik Montavit Ges M.B.H.  
Pharmetics (2011) Inc.  
Phebra Pty Ltd  
Pro Doc Ltée Responded
Purdue Pharma Responded
Ranbaxy Pharmaceuticals Canada Inc. a SUN PHARMA Company Responded
Regulatory Solutions Inc.  
Sandoz Canada Inc. Responded
Sanis Health Inc. (Part of Shopper's Drug Mart) Responded
Sanofi-Aventis Canada Inc. Responded
Shire Pharma Canada ULC Responded
Sivem Pharmaceuticals ULC Responded
SteriMax Inc. Responded
Sterinova Inc.  
Sunovion Pharmaceuticals Canada Inc.  
Tanta Pharmaceuticals Inc.  
Taro Pharmaceuticals Inc. No Response
Teligent Canada Inc. Responded
Teva Canada Limited Responded
Therapeutic Products, Inc.  
UCB Canada Inc.  
Valeant Canada LP No Response
Vita Health Products Inc. Responded
Viva Pharmaceutical Inc.  
Xediton Pharmaceuticals Inc.  

Page details

Date modified: